Overview

Session Description

Bispecific antibodies are a newer class of medications used to treat different cancers. What makes bispecific antibodies unique is the guidance on treatment initiation. This class of medications requires careful monitoring and often inpatient ramp up dosing to monitor for CRS and ICANS.  

Target Audience

Pharmacists in all practice settings.

Learning Objectives

Upon completion of this educational activity learners will be able to:

• Understand the mechanism of action of bispecific antibodies and their emerging role in oncology
• Compare and contrast the available bispecific antibodies in regard to FDA indication, dosing, and use of REMS programs
• Recognize the toxicities of bispecific antibodies, including cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS)
• Identify monitoring strategies for CRS and ICANS during treatment initiation ramp up dosing
• Determine optimal therapy for management of CRS and ICANS based on patient specific factors

Evaluation

All participants will have the opportunity to review the educational sessions and speakers and to identify future educational needs.

Statement of Disclosure

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Standards for Continuing Pharmacy Education, The University of Rhode Island College of Pharmacy requires that program faculty disclose any relationship (e.g., shareholder, recipient of research grant, consultant or member of an advisory committee) that the faculty may have with ineligible companies whose products or services may be mentioned in their presentations. No one involved in the planning of this program has any relevant financial relationships to disclose.

Faculty

Bethany Ramos, PharmD, PGY1 Pharmacy Resident – Kent Hospital

Bethany graduated from the University of Rhode Island College of Pharmacy and is currently a PGY-1 pharmacy resident at Kent Hospital. Her career interests include oncology, psychiatry, and transitions of care. After completion of the residency year, she hopes to continue to work as a clinical pharmacist at Kent Hospital.

CE Credit

Requirements for Credit

Attendance and completion of online program evaluations are required to earn credit. No partial credit is available for this program. Evaluations must be completed at www.uripharmacycpd.org within 60 days.

Pharmacy

The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based program will provide 1.0 Contact Hour (0.1 CEU) for pharmacists. UAN 0060-0000-24-033-L01-P Release Date: June 12, 2024 Expiration Date: August 11, 2024

Registration

Register

• Login or create an account in URI’s learning management and CE reporting system using your email address and professional license number. Complete all required account set up fields to ensure accurate CE reporting.
• Select “Available Live Activities”
• Select Take Post-Test and proceed to secure online payment (Visa, MC, AMEX, Discover or Electronic Checks accepted).
• Registration Fee & Refund Policy
• Registration fee for this program is $7.

Technology

A mobile device or computer with an internet connection is required.